896
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Current treatment options for hereditary angioedema due to C1 inhibitor deficiency

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrea Zanichelli, Vincenzo Montinaro, Massimo Triggiani, Francesco Arcoleo, Debora Visigalli & Mauro Cancian. (2022) Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency. Expert Opinion on Emerging Drugs 27:2, pages 103-110.
Read now
Anna Valerieva, Sonia Caccia & Marco Cicardi. (2018) Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema. Expert Review of Clinical Immunology 14:9, pages 707-718.
Read now

Articles from other publishers (15)

Siobhán Hayes, Colm Farrell, Anurag Relan & John Anderson. (2021) Population pharmacokinetics of recombinant human C1 esterase inhibitor in children with hereditary angioedema. Annals of Allergy, Asthma & Immunology 126:6, pages 707-712.
Crossref
Anne Lesage, Christoph Gibson, François Marceau, Horst-Dieter Ambrosi, Jörn Saupe, Werner Katzer, Brigitte Loenders, Xavier Charest-Morin & Jochen Knolle. (2020) In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist. Frontiers in Pharmacology 11.
Crossref
Maddalena Alessandra Wu, Riccardo Colombo, Gian Marco Podda & Marco Cicardi. (2019) Handling shock in idiopathic systemic capillary leak syndrome (Clarkson’s disease): less is more. Internal and Emergency Medicine 14:5, pages 723-730.
Crossref
Ting Qiu, Maria J. Chiuchiolo, Adele S. Whaley, Anthony R. Russo, Dolan Sondhi, Stephen M. Kaminsky, Ronald G. Crystal & Odelya E. Pagovich. (2019) Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema. Allergy.
Crossref
Anna Valerieva, Marco Cicardi, James Baraniuk & Maria Staevska. (2018) The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures. Allergy, Asthma & Clinical Immunology 14:1.
Crossref
Carlo Federici, Francesca Perego, Ludovica Borsoi, Valentina Crosta, Andrea Zanichelli, Antonio Gidaro, Rosanna Tarricone & Marco Cicardi. (2018) Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients. BMJ Open 8:7, pages e022291.
Crossref
Marco Cicardi & Bruce L. Zuraw. (2018) Angioedema Due to Bradykinin Dysregulation. The Journal of Allergy and Clinical Immunology: In Practice 6:4, pages 1132-1141.
Crossref
Mignon van den Elzen, M. F. C. L. Go, A. C. Knulst, M. A. Blankestijn, H. van Os-Medendorp & H. G. Otten. (2016) Efficacy of Treatment of Non-hereditary Angioedema. Clinical Reviews in Allergy & Immunology 54:3, pages 412-431.
Crossref
Daniel P. TeufelGavin BennettHelen HarrisonKaterine van RietschotenSilvia PavanCatherine StaceFrançois Le Floch, Tine Van Bergen, Elke Vermassen, Philippe Barbeaux, Tjing-Tjing Hu, Jean H. M. Feyen & Marc Vanhove. (2018) Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. Journal of Medicinal Chemistry 61:7, pages 2823-2836.
Crossref
N.T.M.L. Fragnan, A.L.N. Tolentino, G.B. Borba, A.C. Oliveira, J.A. Simões, S.M.U. Palma, R.N. Constantino-Silva & A.S. Grumach. (2018) Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases). Brazilian Journal of Medical and Biological Research 51:12.
Crossref
Scott R. Barnum. (2017) Complement: A primer for the coming therapeutic revolution. Pharmacology & Therapeutics 172, pages 63-72.
Crossref
Lakshmi C. WijeyewickremaEmilie LameignereLilian HorRenee C. DuncanToshikazu ShibaRichard J. Travers, Piyushkumar R. KapoparaVictor LeiStephanie A. Smith, Hugh Kim, James H. Morrissey, Robert N. PikeEdward M. Conway. (2016) Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. Blood 128:13, pages 1766-1776.
Crossref
Daniel Ricklin, Edimara S. Reis & John D. Lambris. (2016) Complement in disease: a defence system turning offensive. Nature Reviews Nephrology 12:7, pages 383-401.
Crossref
Daniel Ricklin & John D. Lambris. (2016) New milestones ahead in complement-targeted therapy. Seminars in Immunology 28:3, pages 208-222.
Crossref
Berhane Ghebrehiwet. (2016) The complement system: an evolution in progress. F1000Research 5, pages 2840.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.